Market Watch Highlights: Indaptus Therapeutics Inc (INDP) Ends on an% Upturn Note at 3.59

Nora Barnes

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

As of close of business last night, Indaptus Therapeutics Inc’s stock clocked out at $3.59, up 2.57% from its previous closing price of $3.5. In other words, the price has increased by $2.57 from its previous closing price. On the day, 0.92 million shares were traded. INDP stock price reached its highest trading level at $4.5 during the session, while it also had its lowest trading level at $3.4.

Ratios:

To gain a deeper understanding of INDP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INDP now has a Market Capitalization of 3972439 and an Enterprise Value of 4351614.

Stock Price History:

The Beta on a monthly basis for INDP is 1.26, which has changed by -0.88947046 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, INDP has reached a high of $58.24, while it has fallen to a 52-week low of $2.22. The 50-Day Moving Average of the stock is -36.73%, while the 200-Day Moving Average is calculated to be -75.05%.

Shares Statistics:

It appears that INDP traded 368.22K shares on average per day over the past three months and 1914250 shares per day over the past ten days. A total of 1.11M shares are outstanding, with a floating share count of 1.00M. Insiders hold about 9.46% of the company’s shares, while institutions hold 4.58% stake in the company. Shares short for INDP as of 1757894400 were 547301 with a Short Ratio of 1.49, compared to 1755216000 on 18667. Therefore, it implies a Short% of Shares Outstanding of 547301 and a Short% of Float of 56.8.

Earnings Estimates

The dynamic stock of Indaptus Therapeutics Inc (INDP) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$4.32, with high estimates of -$4.32 and low estimates of -$4.32.

Analysts are recommending an EPS of between -$26.58 and -$26.58 for the fiscal current year, implying an average EPS of -$26.58. EPS for the following year is -$13.9, with 1.0 analysts recommending between -$13.9 and -$13.9.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.